Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments
Authors:
Open Access
- 1 January 2022
- journal article
- review article
- Published by Aging and Disease in Aging and disease
- Vol. 13 (4) , 1196-1214
Abstract
Hepatic ischemia/reperfusion injury (IRI) is mainly characterized by high activation of immune inflammatory responses and metabolic responses. Understanding the molecular and metabolic mechanisms underlying development of hepatic IRI is critical for developing effective therapies for hepatic IRI. Recent advances in research have improved our understanding of the pathogenesis of IRI. During IRI, hepatocyte injury and inflammatory responses are mediated by crosstalk between the immune cells and metabolic components. This crosstalk can be targeted to treat or reverse hepatic IRI. Thus, a deep understanding of hepatic microenvironment, especially the immune and metabolic responses, can reveal new therapeutic opportunities for hepatic IRI. In this review, we describe important cells in the liver microenvironment (especially non-parenchymal cells) that regulate immune inflammatory responses. The role of metabolic components in the diagnosis and prevention of hepatic IRI are discussed. Furthermore, recent updated therapeutic strategies based on the hepatic microenvironment, including immune cells and metabolic components, are highlighted.Keywords
This publication has 203 references indexed in Scilit:
- Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia–reperfusionJournal of Hepatology, 2012
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in miceHepatology, 2011
- Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioningBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammationJournal of Hepatology, 2011
- Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanismHepatology, 2011
- Mitochondrial calcium and the permeability transition in cell deathBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injuryLiver Transplantation, 2009
- Tezosentan, a Novel Endothelin Receptor Antagonist, Markedly Reduces Rat Hepatic Ischemia and Reperfusion Injury in Three Different ModelsLiver Transplantation, 2008
- Factors in the Pathophysiology of the Liver Ischemia-Reperfusion InjuryJournal of Surgical Research, 2008
- Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via β-catenin activationHepatology, 2007